fda semaglutide compounding warning november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Novo Nordisk expands legal action

Jardiance is an oral tablet (daily pill) available in 10 mg and 25 mg doses, taken once daily with or without food

Underlying Health Conditions: Certain health issues, such as kidney disease, liver impairment, or a history of specific cancers, might contraindicate the use of certain medications or supplements

Antipov South Russian Journal of Therapeutic Practice.2023

14 Early research on the therapeutic potential of GLP-1 was directed towards glucose regulation in diabetes but was extended, through concurrent observations of body weight lowering to obesity management

Investigation: Rafiya Altaf, Fatima Asghar, Rabiya Altaf, Sohaib Tousif

[20,21] However, since GLP-1 were not initially developed with pregnancy, safety and efficacy data in pregnant remain limited